Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?

被引：0

作者：

Spyridonidis, Alexandros ^{[1
,2
,3
,4
]}

机构：

[1] Univ Patras, Bone Marrow Transplantat Unit, Patras, Greece

[2] Univ Patras, Inst Cellular Therapy, Patras, Greece

[3] Univ Patras, Bone Marrow Transplantat Unit, Patras 26504, Greece

[4] Univ Patras, Inst Cellular Therapy, Patras 26504, Greece

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 01期

关键词：

allogeneic; Covid-19; hematopoietic cell transplantation; SARS-CoV-2; transplantation; vaccination;

D O I：

10.1111/bjh.18591

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

When and how often should allogeneic haematopoietic cell transplantation recipients be vaccinated against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is unclear. The report by Bankova et al. suggests that a third SARS-CoV-2 vaccine dose is important but still insufficient in some patients to establish an adequate humoral response. Commentary on: Bankova et al. Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic hematopoietic cell transplantation. Br J Haematol. 2022 (Online ahead of print). doi: 10.1111/bjh.18562. xxx

引用

页码：9 / 10

页数：2

共 7 条

[1] Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation [J].

Einarsdottir, Sigrun ;

Martner, Anna ;

Nicklasson, Malin ;

Wiktorin, Hanna Grauers ;

Arabpour, Mohammad ;

Tornell, Andreas ;

Vaht, Krista ;

Waldenstrom, Jesper ;

Ringlander, Johan ;

Bergstrom, Tomas ;

Brune, Mats ;

Hellstrand, Kristoffer ;

Ljungman, Per ;

Lagging, Martin .

HAEMATOLOGICA, 2022, 107 (06) :1479-1482

[2] Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation [J].

Huang, Alice ;

Cicin-Sain, Caroline ;

Pasin, Chloe ;

Epp, Selina ;

Audige, Annette ;

Mueller, Nicolas J. ;

Nilsson, Jakob ;

Bankova, Andriyana ;

Wolfensberger, Nathan ;

Vilinovszki, Oliver ;

Nair, Gayathri ;

Hockl, Philipp ;

Schanz, Urs ;

Kouyos, Roger D. ;

Hasse, Barbara ;

Zinkernagel, Annelies S. ;

Trkola, Alexandra ;

Manz, Markus G. ;

Abela, Irene A. ;

Mueller, Antonia M. S. .

TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04) :214.e1-214.e11

[3] Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients [J].

Kimura, Muneyoshi ;

Ferreira, Victor H. ;

Kothari, Sagar ;

Pasic, Ivan ;

Mattsson, Jonas, I ;

Kulasingam, Vathany ;

Humar, Atul ;

Mah, Allison ;

Delisle, Jean-Sebastien ;

Ierullo, Matthew ;

Majchrzak-Kita, Beata ;

Kumar, Deepali ;

Hosseini-Moghaddam, Seyed M. .

TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10) :706.e1-706.e10

[4] Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients [J].

Mamez, Anne-Claire ;

Pradier, Amandine ;

Giannotti, Federica ;

Petitpas, Adrien ;

Urdiola, Marta Fabra ;

Vu, Diem-Lan ;

Masouridi-Levrat, Stavroula ;

Morin, Sarah ;

Dantin, Carole ;

Clerc-Renaud, Dominique ;

Eberhardt, Christiane S. ;

Kaiser, Laurent ;

Simonetta, Federico ;

Chalandon, Yves .

BONE MARROW TRANSPLANTATION, 2021, 56 (12) :3094-3096

[5] Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study [J].

Ram, Ron ;

Hagin, David ;

Kikozashvilli, Nino ;

Freund, Tal ;

Amit, Odelia ;

Bar-On, Yael ;

Beyar-Katz, Ofrat ;

Shefer, Gabi ;

Moshiashvili, Miguel Morales ;

Karni, Chen ;

Gold, Ronit ;

Kay, Sigi ;

Glait-Santar, Chen ;

Eshel, Rinat ;

Perry, Chava ;

Avivi, Irit ;

Apel, Arie ;

Benyamini, Noam ;

Shasha, David ;

Ben-Ami, Ronen .

TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09) :788-794

[6] Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT [J].

Redjoul, Rabah ;

Le Bouter, Anne ;

Parinet, Vincent ;

Fourati, Slim ;

Maury, Sebastien .

LANCET HAEMATOLOGY, 2021, 8 (10) :E681-E683

[7] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients [J].

Shem-Tov, Noga ;

Yerushalmi, Ronit ;

Danylesko, Ivetta ;

Litachevsky, Vladislav ;

Levy, Itzchak ;

Olmer, Liraz ;

Lusitg, Yaniv ;

Avigdor, Abraham ;

Nagler, Arnon ;

Shimoni, Avichai ;

Rahav, Galia .

BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) :884-891

← 1 →